Philips stock week brings UniGuide imaging and Lumea launches

Philips entered the final week of October with two product launches spanning professional healthcare and personal health. The developments broaden the company narrative ahead of its third-quarter results on Tuesday, November 3, 2026.

Imaging platform gains new function

On October 29, Royal Philips announced UniGuide 3D Live Guidance for Europe and other CE-marked markets. The system connects preprocedural CT insights with the live workflow of the Azurion image-guided therapy platform, supporting PCI, structural heart and complex vascular procedures. Philips said the solution is available for sale in CE-marked markets from October 23 and is not currently available in the United States. The announcement was published by Philips.

Personal health targets home users

Philips also launched the Lumea 9900 Pro on October 27. The at-home IPL device combines real-time audio feedback with motion guidance and was offered at a recommended retail price of 799.99 euros, according to Morningstar, carrying PR Newswire content. The product adds a consumer-facing element to Philips' health technology portfolio.

Quote and next scheduled catalyst

Philips stock traded at 24.24 euros on Lang & Schwarz at 10:27 Berlin time on Saturday, October 31, 2026. Investors' next scheduled company event is the third-quarter report on November 3, when management updates will provide the next read-through on demand, margins and execution.

Investors can follow the real-time quote of Philips stock for the latest trading indication.

Broader Dutch equities will be viewed against the AEX market backdrop.

More news and analysis is available on Philips stock.